Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: a randomized, double-blind, placebo-controlled trial

BACKGROUND: Increasing evidence suggests the bidirectional interplay between parathyroid hormone and aldosterone as an important mechanism behind the increased risk of cardiovascular damage and bone disease observed in primary hyperparathyroidism. Our primary object is to assess the efficacy of the...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Tomaschitz, Andreas, Fahrleitner-Pammer, Astrid, Pieske, Burkert, Verheyen, Nicolas, Amrein, Karin, Ritz, Eberhard, Kienreich, Katharina, Horina, Jörg H, Schmidt, Albrecht, Kraigher-Krainer, Elisabeth, Colantonio, Caterina, Meinitzer, Andreas, Pilz, Stefan
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2012
Teme:
Study Protocol
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3515510/
https://ncbi.nlm.nih.gov/pubmed/22974443
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1472-6823-12-19
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki